Achilles Therapeutics plc Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2019 to 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Achilles Therapeutics plc annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2019 to 2023.
  • Achilles Therapeutics plc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending April 1, 2023 was 0.25 pure.
  • Achilles Therapeutics plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.24 pure, a 21.1% increase from 2022.
  • Achilles Therapeutics plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.19 pure, unchanged from 2021.
  • Achilles Therapeutics plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.19 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 0.24 +0.04 +21.1% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-04
2022 0.19 0 0% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-04
2021 0.19 0 0% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-04
2020 0.19 0 0% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 0.19 Jan 1, 2019 Dec 31, 2019 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.